Navigation Links
European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Date:9/24/2007

sease who have not been previously treated with interferon alpha and who are at least 18 years of age. PEGINTRON is not indicated in the United States for retreatment of patients who failed previous interferon therapy.

Important Safety Information Regarding U.S. Labeling for PEGINTRON and REBETOL

Alpha interferons, including PEGINTRON and INTRON(R) A, may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Patients with persistently severe or worsening signs or symptoms of these conditions should be withdrawn from therapy. In many, but not all cases, these disorders resolve after stopping PEGINTRON and/or INTRON A therapy.

Use with Ribavirin: Ribavirin may cause birth defects and/or death of the unborn child. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients. Ribavirin causes hemolytic anemia. The anemia associated with REBETOL therapy may result in a worsening of cardiac disease. Ribavirin is genotoxic and mutagenic and should be considered a potential carcinogen

Contraindications

PEGINTRON is contraindicated in patients with hypersensitivity to PEGINTRON or any other component of the product, autoimmune hepatitis, and hepatic decompensation (Child-Pugh score greater than 6 [class B and C]) in cirrhotic CHC patients before or during treatment. INTRON A (Interferon alfa- 2b, recombinant) for Injection is contraindicated in patients with hypersensitivity to INTRON A or any component of the product, autoimmune hepatitis, and decompensated liver disease. PEGINTRON or INTRON A in combination with REBETOL therapy is additionally contraindicated in patients with hypersensitivity to ribavirin or any other component of the product, women who are pregnant, men whose female partners are pregnant, patients with hemoglobinopathies (e.g., thalassemia
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Malvern initiates European user group meetings for chemical imaging
7. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
8. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
9. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
10. Inspire Announces Presentations at Two European Scientific Conferences
11. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 2014 /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in ... its Mylan-Nitro Spray 0.4 mg/metered dose due to the product ... component. A missing "dip tube" could pose ... patient. This defect may lead patients to believe they are ... access it. Not receiving nitroglycerin could place them at risk ...
(Date:9/19/2014)... , Sept. 19, 2014 Medical ... forging relationships with key opinion leaders (KOLs) who ... competition. Despite the critical nature of the MSL ... challenges, including altering the landscape for creating and ... According to research, the oversight responsibility for the ...
(Date:9/19/2014)... 19, 2014 Harwood Feffer LLP ( www.hfesq.com ... directors of PDL BioPharma, Inc. ("PDL" or the "Company") ... has breached its fiduciary duties to shareholders or violated ... 2014, the Company disclosed: "On September 11, 2014, [PDL] ... Ernst & Young LLP ("EY"), that it was resigning ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... a,division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today,that the ... pediatric,exclusivity for TOPAMAX(R) (topiramate), based on studies submitted ... to investigate the use of TOPAMAX,in pediatric patients ... seizures., In addition to granting pediatric exclusivity, ...
... There are a record 301,new medicines being ... released here today during a briefing that focused ... patients, their families,and society. Nationwide, mental illness affects ... the Pharmaceutical Research and Manufacturers,of America (PhRMA), featured ...
Cached Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer ... party dresses . In addition, the company has launched a ... the promotion is to benefit all of its big fans. ... store now. , Along with beautiful party dresses, the ... has recently released its new sexy short prom outfits and ...
(Date:9/20/2014)... (PRWEB) September 21, 2014 Recently, UWDress.com, ... has launched a promotion for its newly announced ... most of the company’s special occasion outfits are very ... outfits are provided with big savings (up to 65 ... hard to offer more fashionable special occasion outfits for ...
(Date:9/20/2014)... NV (PRWEB) September 21, 2014 ... Dr. Kenneth Pullman that is helping thousands of people ... diabetes symptoms without shots, pills, or prescriptions has caught ... , “There are currently tens of millions of ... Type 1 and Type 2 diabetes, and unfortunately, big ...
(Date:9/20/2014)... 21, 2014 Weight Destroyer , ... fitness expert Michael Wren that has already helped tens ... reverse health conditions like high blood pressure, high cholesterol, ... Michaels, prompting an investigative review. , “Weight Destroyer ... upside down by showing people what is truly effective ...
(Date:9/20/2014)... 6 Minutes to Skinny , a ... Ballantyne that is showing men and women of all ages ... body fat using simple 6-minute exercises and easy-to-follow lifestyle tips ... investigative review. , “When it comes to losing body ... out for all people,” reports Michaels. “Metabolism plays a big ...
Breaking Medicine News(10 mins):Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2
... cancer is expected to be unsuccessful. Statisticians with the US ... in the hunt for common inherited genetic variants that would ... there are a number of problems when doing such a ... that common genes are unlikely to exist nor have ...
... With one of the highest percentages of undernourished children ... states a new World Bank report released Thursday//. ... significant changes to address the current malnutrition crisis," states ... and Action". ,The prevalence of underweight children in ...
... Cancer Institute in Bethesda, Maryland, and Jaakko Kaprio, a genetic ... waste of time and money to search for genes linked ... Medical Journal. They say that there is very little chance ... is being invested. Researchers believe that if they can identify ...
... should practice less invasive surgery for by pass surgery. They ... increase the chances of exposing patients to innumerable infections. Most ... infections. In the traditional method the great saphenous vein is ... This enhances the blood flow to the heart muscle ...
... of the American Society of Nephrology has stated that ... failure//. ,"Our results confirm an accumulating body of ... causative factor in kidney disease," comments Dr. Elisabeth Ejerblad ... study. ,Dr. Ejerblad and colleagues assessed body mass ...
... will help cigarette smokers to quit smoking, wins ... active ingredient in Chantix is varenicline tartrate. The ... better effectiveness shown in preliminary trials compared to ... priority review get approved or rejected within six ...
Cached Medicine News:Health News:Malnutrition Crisis On Rise In India: World Bank 2Health News:Kidney Failure three times pronounced with obesity 2
An entirely new way to brighten and enhance natural eye color....
Disposable-type color lenses for exciting eye color change....
... The world standard in corneal ... like endothelium, descemet's membrane, stroma, Bowman's ... of Corneal Components. Broad Applications in ... pachymetry, post-surgery interface evaluation, endothelial cell ...
... Vasculight SR improves the appearance of photo-aged ... benign brown pigments, telangiectasias, and broken capillaries. ... pulsed light (IPLTM) treats pigmentary sun damage ... combined approach of IPL and the Nd:YAG ...
Medicine Products: